Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Peak effect timing matters for injection scheduling
Ongoing clinical trials are currently investigating a single-dose regimen of Danuglipron for managing overweight and obesity (NCT04616339)
Reduces hunger and cravings by acting on appetite centers in the brain Slows stomach emptying, helping you feel full longer Improves blood sugar control, reducing insulin spikes Patients typically lose up to 15% of body weight when combined with diet and exercise
Case reports of retained solid gastric content in patients undergoing anesthesia
US$ 28.90
US$ 25.85
US$ 24.87
